EBITDA: Income before interest, taxes, depreciation and amortization.
BioLargo, Inc. (BLGO) had EBITDA of $-3.35M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$1.09M |
|
$-2.60M |
|
$0.57M |
|
$0.52M |
|
$4.61M |
|
$-3.52M |
|
$-0.30M |
|
$-3.82M |
|
$-3.82M |
|
$-3.82M |
|
$-3.82M |
|
$-3.82M |
|
$-3.82M |
|
$-3.52M |
|
|
EBITDA |
$-3.35M |
329.08M |
|
329.08M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$3.54M |
|
$1.68M |
|
$3.67M |
|
$7.21M |
|
$5.94M |
|
$5.20M |
|
$6.03M |
|
$11.96M |
|
$-4.75M |
|
$-4.75M |
|
$-4.75M |
|
334.84M |
|
| Cash Flow Statement Financials | |
$-8.18M |
|
$-0.23M |
|
$6.08M |
|
$3.88M |
|
$1.53M |
|
$-2.35M |
|
$2.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.60 |
|
-- |
|
-- |
|
11.51 |
|
-1.42 |
|
47.34% |
|
-323.12% |
|
-323.12% |
|
-- |
|
-350.83% |
|
-238.72% |
|
$-8.42M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
1.78 |
|
0.77 |
|
117.00 |
|
80.49% |
|
80.49% |
|
-53.01% |
|
-846.02% |
|
$-0.01 |
|
$-0.03 |
|
$-0.02 |
|